Directive No. 02/1999/CT-BYT of the Minister of Health on Strengthening the Management of Narcotic Drugs and Psychotropic Substances requires healthcare units and pharmaceutical enterprises to implement stricter control measures to ensure safety and effectiveness in drug usage.
适用范围
Directors of Health Departments of provinces and centrally administered cities; Heads of units under the Ministry of Health; Military Medical Department - Ministry of National Defense; Public Security Health Department - Ministry of Public Security; Director of the Health Department of the Ministry of Transport; Heads of health sectors.
要点
- Directors of Health Departments and Heads of units under the Ministry of Health → organize training for staff on managing narcotic drugs, psychotropic substances, and related legal regulations.
- Pharmaceutical enterprises → shall not purchase floating drugs on the market or from individual establishments without pharmaceutical business functions.
- Hospitals and treatment departments → strictly manage the use of narcotic drugs and psychotropic substances, carry out procedures for recovery when necessary.
- Units producing and trading in pharmaceutical products → shall not purchase floating drugs on the market or from individual establishments without pharmaceutical business functions.
- Pharmaceutical enterprises permitted to trade in narcotic drugs and psychotropic substances → organize retail stores according to prescriptions to meet patients' treatment needs.
🌐 本文件的社会影响
- Strengthening strict management helps reduce illegal trafficking and improper use, protecting public health.
- Compliance with regulations may cause pharmaceutical enterprises difficulties in purchasing raw materials for drug production.
- Patients will be guaranteed drug supply according to prescriptions, avoiding shortages or improper use.
❓ 常见问题
Where can pharmaceutical enterprises purchase narcotic drugs and psychotropic substances?
According to the Directive, pharmaceutical enterprises shall not purchase floating drugs on the market or from establishments or individuals without pharmaceutical business functions. They are only allowed to purchase from official manufacturers with permits.
What measures should hospitals take to manage narcotic drugs and psychotropic substances?
Hospitals need to strictly manage drug usage, ensuring that drugs reach patients and preventing loss. In cases where unused drugs remain, they must carry out procedures for recovery and return them to the Pharmacy Department.
Are there any regulations regarding the retail sale of narcotic drugs and psychotropic substances?
According to the Directive, enterprises permitted to trade these types of drugs must organize retail sales according to prescriptions to meet patients' treatment needs.
What consequences will pharmaceutical enterprises face if they violate regulations?
If violating the Regulations on Managing Narcotic Drugs and the Regulations on Managing Psychotropic Substances, enterprises will be dealt with severely and promptly according to regulations.
What procedures should hospitals follow when there are unused drugs?
In cases where patients die, transfer to another hospital, or for some reason drugs are not used or are left over, hospitals must carry out procedures for recovery and return them to the Pharmacy Department.
全文
DIRECTIVE OF THE MINISTER OF HEALTH
On the strengthening of management of narcotic drugs and psychotropic substances
To manage narcotic drugs and psychotropic substances, the Ministry of Health has issued the following documents: Directive No. 09/BYT-CT dated June 11, 1993 of the Minister of Health on Strengthening the Management of Narcotic Drugs, the Regulation on the Management of Narcotic Drugs issued together with Decision No. 939/BYT-QĐ dated June 6, 1995 of the Minister of Health, and the Regulation on the Management of Psychotropic Substances issued together with Decision No. 2330/1997/QĐ-BYT dated November 8, 1997 of the Minister of Health.
During the implementation of these Regulations, generally, the management of narcotic drugs and psychotropic substances has been standardized at all stages of production, import, circulation, and distribution, especially in state-owned pharmaceutical enterprises. However, recently, through inspections conducted jointly by provincial health departments and law enforcement agencies, some violations of the Regulations have been discovered, such as illegal storage and sale of narcotic drugs by some private pharmacies. Medical staff in a hospital have also been found to have taken out some narcotic drugs (by reducing patients' drug quantities or unused amounts according to doctors' prescriptions) and sold them to private pharmacies, causing negative impacts on the industry's reputation and social security.
To further strengthen the management of narcotic drugs and psychotropic substances and ensure adequate supply for treatment needs, the Minister of Health issues this directive to the directors.
Provincial and municipal health departments under the central government, heads of units directly under the Ministry of Health are instructed to guide subordinate units within their jurisdiction to implement the following matters:
1. Organize training sessions on Circulars, Directives, and Regulations on the management of narcotic drugs, the management of psychotropic substances, and related legal provisions for units and individuals to better understand the importance of managing these types of drugs.
2. Enhance inspection work on compliance with the Regulations on the management of narcotic drugs and the Regulations on the management of psychotropic substances at pharmaceutical production and trading units, pharmacies, and departments in hospitals.
3. Hospitals and treatment departments must strictly manage the use of narcotic drugs and psychotropic substances to ensure that they reach patients and prevent losses that could lead to adverse consequences. In cases where patients die, transfer to another hospital, or for any other reason where the drugs are not used or are not fully used, procedures must be followed to return the remaining drugs to the Pharmacy Department.
4. Pharmaceutical production and trading units, medical examination and treatment facilities are not allowed to purchase narcotic drugs and psychotropic substances from unregulated sources in the market or from entities or individuals without pharmaceutical trading functions.
5. Enterprises permitted to trade in narcotic drugs and psychotropic substances must organize retail outlets based on prescriptions to meet the treatment needs of patients and avoid situations where patients have prescriptions but cannot obtain the drugs.
6. Properly implement regulations on inventory checks and stock reports as stipulated in the Regulation on the Management of Narcotic Drugs and the Regulation on the Management of Psychotropic Substances.
7. Take strict and timely measures to deal with violations of the Regulations on the management of narcotic drugs and the Regulations on the management of psychotropic substances.
Upon receipt of this Directive, the heads of units directly under the Ministry, directors of provincial health departments, the Director of the Military Medicine Bureau - Ministry of National Defense, the Director of the Public Security Medicine Bureau - Ministry of Public Security, the Director of the Health Department - Ministry of Transport, and the heads of health sectors must strictly implement this Directive./.
关系图
点击文件即可打开。红色边框＝改变效力的关系。